November 12, 2026 · Contraception · DOI: 10.1016/j.contraception.2026.111761

The association between antiretroviral therapy regimen and contraceptive failure among Malawian women living with HIV using injectable, progestin-based hormonal contraception.

Listen to this summary

This study asked whether efavirenz-based versus dolutegravir-based antiretroviral therapy increases pregnancy risk among Malawian women with HIV who use depot medroxyprogesterone acetate (DMPA) contraception. Using marginal structural models on FP-ART cohort data, the researchers found no statistically clear elevation in pregnancy rates with consistent efavirenz use among women taking DMPA as prescribed (IRR 1.90, 95% CI 0.67–5.40), though the wide confidence intervals limit firm conclusions. The authors conclude that the findings add to evidence of a possible efavirenz–DMPA interaction and support the safety of dolutegravir-based regimens for this population.

Karen Diepstra, Daniel Westreich, Mackenzie Cottrell, Audrey Pettifor, Mollie E Wood, Agatha Bula, Clara Lemani, John Chapola, Jennifer Winston, Katie R Mollan, Jill Hagey, Sam Phiri, Lameck Chinula, David W Erikson, Mina C Hosseinipour, Jennifer H Tang

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play